| JDMAX | VRKSX | JDMAX / VRKSX | |
| Total Expense Ratio | 1.14 | 0.89 | 128% |
| Annual Report Gross Expense Ratio | 1.14 | 1.92 | 59% |
| Fund Existence | 17 years | 6 years | - |
| Gain YTD | 6.857 | -1.072 | -640% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 2500000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 22.4B | 6.2M | 361,349% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 1.10 | -11.35 | -10% |
| Returns for 3 years | 8.01 | 6.06 | 132% |
| Returns for 5 years | -15.46 | -8.39 | 184% |
| Returns for 10 years | 53.51 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GTSGX | 16.98 | 0.20 | +1.19% |
| Madison Mid Cap Y | |||
| HNISX | 17.56 | 0.10 | +0.57% |
| Harbor International Small Cap Retire | |||
| SHSKX | 67.85 | 0.11 | +0.16% |
| BlackRock Health Sciences Opps K | |||
| TRGMX | 18.57 | -0.15 | -0.80% |
| Nuveen Quant Mid Cap Growth Retire | |||
| RYMMX | 70.94 | -0.58 | -0.81% |
| Rydex S&P MidCap 400 Pure Value C | |||